{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:54:32Z","timestamp":1768002872305,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00345-008-0284-x","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T17:48:25Z","timestamp":1214934505000},"page":"359-364","source":"Crossref","is-referenced-by-count":55,"title":["Lower urinary-tract symptoms and testosterone in elderly men"],"prefix":"10.1007","volume":"26","author":[{"given":"Aksam A.","family":"Yassin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed I.","family":"El-Sakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis J. G.","family":"Gooren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,2]]},"reference":[{"key":"284_CR1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.urology.2007.01.011","volume":"69","author":"S Rohrmann","year":"2007","unstructured":"Rohrmann S, Nelson WG, Rifai N, Kanarek N, Basaria S, Tsilidis KK, Smit E, Giovannucci E, Platz EA (2007) Serum sex steroid hormones and lower urinary tract symptoms in third national health and nutrition examination survey (NHANES III). Urology 69:708\u2013713","journal-title":"Urology"},{"key":"284_CR2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","volume":"26","author":"JM Kaufman","year":"2005","unstructured":"Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833\u2013876","journal-title":"Endocr Rev"},{"key":"284_CR3","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.juro.2006.08.005","volume":"176","author":"AI El-Sakka","year":"2006","unstructured":"El-Sakka AI, Hassoba HM (2006) Age related testosterone depletion in patients with erectile dysfunction. J Urol 176:2589\u20132593","journal-title":"J Urol"},{"key":"284_CR4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0090-4295(02)02252-5","volume":"61","author":"G Schatzl","year":"2003","unstructured":"Schatzl G, Madersbacher S, Temml C, Krenn-Schinkel K, Nader A, Sregi G, Lapin A, Hermann M, Berger P, Marberger M (2003) Serum androgen levels in men: impact of health status and age. Urology 61:629\u2013633","journal-title":"Urology"},{"key":"284_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1464-410X.2007.06938.x","volume":"100","author":"HJ Litman","year":"2007","unstructured":"Litman HJ, Bhasin S, O\u2019Leary MP, Link CL, McKinlay JB (2007) An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int 100:321\u2013326","journal-title":"BJU Int"},{"key":"284_CR6","doi-asserted-by":"crossref","unstructured":"Koritsiadis G, Stravodimos K, Mitropoulos D, Doumanis G, Fokitis I, Koritsiadis S, Constantinides C (2008) Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int 101:1542\u20131546 (E-pub)","DOI":"10.1111\/j.1464-410X.2008.07521.x"},{"key":"284_CR7","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2006-0401","volume":"91","author":"M Zitzmann","year":"2006","unstructured":"Zitzmann M, Faber S, Nieschlag E (2006) Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335\u20134343","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ncpuro0706","volume":"4","author":"M Zitzmann","year":"2007","unstructured":"Zitzmann M (2007) Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat Clin Pract Urol 4:161\u2013166","journal-title":"Nat Clin Pract Urol"},{"issue":"suppl 1","key":"284_CR9","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S0007114500000957","volume":"83","author":"P Bjorntorp","year":"2000","unstructured":"Bjorntorp P, Rosmond R (2000) The metabolic syndrome: a neuroendocrine disorder? Br J Nutr 83(suppl 1):S49\u2013S57","journal-title":"Br J Nutr"},{"key":"284_CR10","first-page":"1853","volume":"83","author":"R Rosmond","year":"1998","unstructured":"Rosmond R, Dallman MF, Bjorntorp P (1998) Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853\u20131859","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","volume":"174","author":"KT McVary","year":"2005","unstructured":"McVary KT, Rademaker A, Lloyd GL, Gann P (2005) Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 174:1327\u20131433","journal-title":"J Urol"},{"key":"284_CR12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11934-996-0008-y","volume":"7","author":"S Kasturi","year":"2006","unstructured":"Kasturi S, Russell S, McVary KT (2006) Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep 7:288\u2013292","journal-title":"Curr Urol Rep"},{"key":"284_CR13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.urology.2007.04.048","volume":"70","author":"PM Ullrich","year":"2007","unstructured":"Ullrich PM, Lutgendorf SK, Kreder KJ (2007) Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia. Urology 70:487\u2013491 discussion 491\u2013482","journal-title":"Urology"},{"key":"284_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/pros.20110","volume":"62","author":"S Rohrmann","year":"2005","unstructured":"Rohrmann S, De Marzo AM, Smit E, Giovannucci E, Platz EA (2005) Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 62:27\u201333","journal-title":"Prostate"},{"key":"284_CR15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.metabol.2007.07.002","volume":"56","author":"H Teoh","year":"2007","unstructured":"Teoh H, Verma S (2007) C-reactive protein, metabolic syndrome, and end organ damage. Metabolism 56:1620\u20131622","journal-title":"Metabolism"},{"key":"284_CR16","unstructured":"El-Sakka AI, Sayed HM, Tayeb KA (2007) Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl 18 Sep [Epub ahead of print] PMID: 17877718"},{"key":"284_CR17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","volume":"17","author":"AG Renehan","year":"2006","unstructured":"Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17:328\u2013336","journal-title":"Trends Endocrinol Metab"},{"key":"284_CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000052430","volume":"39","author":"J Hammarsten","year":"2001","unstructured":"Hammarsten J, Hogstedt B (2001) Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39:151\u2013158","journal-title":"Eur Urol"},{"key":"284_CR19","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1210\/jc.2007-0454","volume":"92","author":"MA Yialamas","year":"2007","unstructured":"Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ (2007) Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92:4254\u20134259","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1743-6109.2005.00132.x","volume":"3","author":"AI El-Sakka","year":"2006","unstructured":"El-Sakka AI (2006) Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors. J Sex Med 3:144\u2013149","journal-title":"J Sex Med"},{"key":"284_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.mou.0000193366.53705.ce","volume":"16","author":"RC Rosen","year":"2006","unstructured":"Rosen RC (2006) Update on the relationship between sexual dysfunction and lower urinary tract symptoms\/benign prostatic hyperplasia. Curr Opin Urol 16:11\u201319","journal-title":"Curr Opin Urol"},{"issue":"suppl 2","key":"284_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-410X.2006.06102.x","volume":"97","author":"K McVary","year":"2006","unstructured":"McVary K (2006) Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97(suppl 2):23\u201328 discussion 44-25","journal-title":"BJU Int"},{"key":"284_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0272.2006.00709.x","volume":"38","author":"A Yassin","year":"2006","unstructured":"Yassin A, Saad F, Hoesl CE, Traish AM, Hammadeh M, Shabsigh R (2006) Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH\/LUTS: implications for clinical practice. Andrologia 38:1\u201312","journal-title":"Andrologia"},{"key":"284_CR24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.eururo.2005.04.032","volume":"48","author":"AI El-Sakka","year":"2005","unstructured":"El-Sakka AI (2005) Lower urinary tract symptoms in patients with erectile dysfunction: is there a vascular association? Eur Urol 48:319\u2013325","journal-title":"Eur Urol"},{"key":"284_CR25","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.juro.2006.06.003","volume":"176","author":"SA Kaplan","year":"2006","unstructured":"Kaplan SA, Meehan AG, Shah A (2006) The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome: what are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 176:1524\u20131527 discussion 1527\u20131528","journal-title":"J Urol"},{"key":"284_CR26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2005.02299.x","volume":"63","author":"D Kapoor","year":"2005","unstructured":"Kapoor D, Malkin CJ, Channer KS, Jones TH (2005) Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63:239\u2013250","journal-title":"Clin Endocrinol (Oxf)"},{"key":"284_CR27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","volume":"63","author":"AM Isidori","year":"2005","unstructured":"Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 63:280\u2013293","journal-title":"Clin Endocrinol (Oxf)"},{"key":"284_CR28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/01.ju.0000165389.73148.d1","volume":"174","author":"R Shabsigh","year":"2005","unstructured":"Shabsigh R, Perelman MA, Lockhart DC, Lue TF, Broderick GA (2005) Health issues of men: prevalence and correlates of erectile dysfunction. J Urol 174:662\u2013667","journal-title":"J Urol"},{"key":"284_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jc.2007-1291","volume":"93","author":"CA Allan","year":"2007","unstructured":"Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI (2007) Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non-obese aging men. J Clin Endocrinol Metab 93:139\u2013146","journal-title":"J Clin Endocrinol Metab"},{"key":"284_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/nau.1930140114","volume":"14","author":"BA Rosenzweig","year":"1995","unstructured":"Rosenzweig BA, Bolina PS, Birch L, Moran C, Marcovici I, Prins GS (1995) Location and concentration of estrogen, progesterone, and androgen receptors in the bladder and urethra of the rabbit. Neurourol Urodyn 14:87\u201396","journal-title":"Neurourol Urodyn"},{"key":"284_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-4328(99)00084-4","volume":"105","author":"JR Keast","year":"1999","unstructured":"Keast JR (1999) The autonomic nerve supply of male sex organs\u2013an important target of circulating androgens. Behav Brain Res 105:81\u201392","journal-title":"Behav Brain Res"},{"key":"284_CR32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0306-4522(99)00237-7","volume":"93","author":"TW Watkins","year":"1999","unstructured":"Watkins TW, Keast JR (1999) Androgen-sensitive preganglionic neurons innervate the male rat pelvic ganglion. Neuroscience 93:1147\u20131157","journal-title":"Neuroscience"},{"key":"284_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0014-2999(02)02047-2","volume":"449","author":"R Hall","year":"2002","unstructured":"Hall R, Andrews PL, Hoyle CH (2002) Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder. Eur J Pharmacol 449:301\u2013309","journal-title":"Eur J Pharmacol"},{"key":"284_CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11010-007-9415-8","volume":"301","author":"YS Juan","year":"2007","unstructured":"Juan YS, Onal B, Broadaway S, Cosgrove J, Leggett RE, Whitbeck C, De E, Sokol R, Levin RM (2007) Effect of castration on male rabbit lower urinary tract tissue enzymes. Mol Cell Biochem 301:227\u2013233","journal-title":"Mol Cell Biochem"},{"key":"284_CR35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/en.2006-1079","volume":"148","author":"S Filippi","year":"2007","unstructured":"Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M, Forti G, Maggi M (2007) Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148:1019\u20131029","journal-title":"Endocrinology"},{"key":"284_CR36","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.eururo.2006.09.014","volume":"50","author":"KT McVary","year":"2006","unstructured":"McVary KT (2006) Unexpected insights into pelvic function following phosphodiesterase manipulation: what\u2019s next for urology? Eur Urol 50:1153\u20131156","journal-title":"Eur Urol"},{"key":"284_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00297196","volume":"22","author":"I Ehren","year":"1994","unstructured":"Ehren I, Adolfsson J, Wiklund NP (1994) Nitric oxide synthase activity in the human urogenital tract. Urol Res 22:287\u2013290","journal-title":"Urol Res"},{"key":"284_CR38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-4522(95)00453-X","volume":"71","author":"PJ Smet","year":"1996","unstructured":"Smet PJ, Jonavicius J, Marshall VR, de Vente J (1996) Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry. Neuroscience 71:337\u2013348","journal-title":"Neuroscience"},{"key":"284_CR39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00240-001-0221-6","volume":"29","author":"Y Qiu","year":"2001","unstructured":"Qiu Y, Kraft P, Craig EC, Liu X, Haynes-Johnson D (2001) Identification and functional study of phosphodiesterases in rat urinary bladder. Urol Res 29:388\u2013392","journal-title":"Urol Res"},{"key":"284_CR40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1464-410X.2006.06217.x","volume":"98","author":"V Werkstrom","year":"2006","unstructured":"Werkstrom V, Svensson A, Andersson KE, Hedlund P (2006) Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. BJU Int 98:414\u2013423","journal-title":"BJU Int"},{"key":"284_CR41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0015-0282(16)57555-4","volume":"63","author":"SL Chamness","year":"1995","unstructured":"Chamness SL, Ricker DD, Crone JK, Dembeck CL, Maguire MP, Burnett AL, Chang TS (1995) The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101\u20131107","journal-title":"Fertil Steril"},{"key":"284_CR42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s003450100221","volume":"19","author":"MC Truss","year":"2001","unstructured":"Truss MC, Stief CG, Uckert S, Becker AJ, Wefer J, Schultheiss D, Jonas U (2001) Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside. World J Urol 19:344\u2013350","journal-title":"World J Urol"},{"key":"284_CR43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1464-410X.2002.03040.x","volume":"90","author":"K Sairam","year":"2002","unstructured":"Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC (2002) Sildenafil influences lower urinary tract symptoms. BJU Int 90:836\u2013839","journal-title":"BJU Int"},{"key":"284_CR44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1743-6109.04047.x","volume":"1","author":"F Montorsi","year":"2004","unstructured":"Montorsi F, Corbin J, Phillips S (2004) Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention. J Sex Med 1:322\u2013336","journal-title":"J Sex Med"},{"key":"284_CR45","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.eururo.2006.05.025","volume":"50","author":"S Uckert","year":"2006","unstructured":"Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG (2006) Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol 50:1194\u20131207 discussion 1207","journal-title":"Eur Urol"},{"key":"284_CR46","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1743-6109.2006.00259.x","volume":"3","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Guhring P, Parker M, Hopps C (2006) Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 3:662\u2013667","journal-title":"J Sex Med"},{"key":"284_CR47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","volume":"177","author":"KT McVary","year":"2007","unstructured":"McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177:1071\u20131077","journal-title":"J Urol"},{"key":"284_CR48","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/nau.20485","volume":"26","author":"KE Andersson","year":"2007","unstructured":"Andersson KE, Uckert S, Stief C, Hedlund P (2007) Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn 26:928\u2013933","journal-title":"Neurourol Urodyn"},{"key":"284_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/pros.2990230203","volume":"23","author":"S Holmang","year":"1993","unstructured":"Holmang S, Marin P, Lindstedt G, Hedelin H (1993) Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men. Prostate 23:99\u2013106","journal-title":"Prostate"},{"key":"284_CR50","unstructured":"Mskhalaya G, Rozhivanov, RV, Nesterov, MN, Kalinchenko, SY (2006) The efficiency and safety of human chorionic gonadotropin (HCG) therapy on low urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). In: Fifth congress of the International Society for the Study of the Aging Male. Salzburg, Austria"},{"key":"284_CR51","unstructured":"Karazindiyano\u011flu S, \u00c7ayan S (2007) Beneficial effects of testosterone administration of bladder function. In: European Association of Urology, Berlin, Germany"},{"key":"284_CR52","unstructured":"Mskhalaya G, Tishova JA, Koval AN, Vishnevskiy EL, Kalinchenko SY (2007) The efficiency of testosterone undecanoat (Nebido) therapy on lower urinary tract symptoms (LUTS) in men with late-onset hypogonadism (LOH). In: 1st European congress of the Society for the Study of the Aging Male. Warsaw, Poland"},{"key":"284_CR53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/01485010701730880","volume":"53","author":"LJ Saad FG","year":"2007","unstructured":"Saad FG LJ, Haider A, Yassin A (2007) An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome. Arch Androl 53:353\u2013357","journal-title":"Arch Androl"},{"key":"284_CR54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2164\/jandrol.107.002774","volume":"29","author":"F Saad","year":"2008","unstructured":"Saad F, Gooren LJ, Haider A, Yassin A (2008) A dose\u2013response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 29:102\u2013105","journal-title":"J Androl"},{"key":"284_CR56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1464-410X.2007.06609.x","volume":"99","author":"C Robertson","year":"2007","unstructured":"Robertson C, Link CL, Onel E, Mazzetta C, Keech M, Hobbs R, Fourcade R, Kiemeney L, Lee C, Boyle P, McKinlay JB (2007) The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies. BJU Int 99:347\u2013354","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-008-0284-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T20:35:11Z","timestamp":1631478911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-008-0284-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,2]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1007\/s00345-008-0284-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,2]]}}}